SCHEMBL8957372

SCHEMBL8957372

O=[N+]([O-])OCC(c1ccccc1)c1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSR P00390 1/20 0.50
CA12 O43570 2/20 0.42
CA1 P00915 2/20 0.42
CA2 P00918 2/20 0.42
CA9 Q16790 2/20 0.42
CA7 P43166 1/20 0.42
PTGS2 P35354 5/20 0.42
PTGS1 P23219 3/20 0.42
NPC1 O15118 2/20 0.40
MEN1 O00255 1/20 0.40
POLB P06746 1/20 0.40
KMT2A Q03164 1/20 0.40
ADAM17 P78536 1/20 0.40
ALDH1A1 P00352 2/20 0.38
HTR2A P28223 1/20 0.38
TAAR1 Q96RJ0 1/20 0.38
LMNA P02545 1/20 0.38
CNR1 P21554 2/20 0.36
CNR2 P34972 2/20 0.36
GAA P10253 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9872237 0.84 GSR (0.47) GSRPTGS2PTGS1NPC1MEN1
SCHEMBL14000549 0.82 SCN4A (0.52) GSRPTGS2
SCHEMBL4587515 0.82 SCN4A (0.52) GSRPTGS2
SCHEMBL9803273 0.81 GSR (0.67) GSRCA12CA1CA2CA9
SCHEMBL8957388 0.80 GSR (0.47) GSRPTGS2PTGS1NPC1ADAM17
SCHEMBL17645108 0.77 MEN1 (0.58) MEN1POLBKMT2AALDH1A1GAA
SCHEMBL17645312 0.77 MEN1 (0.58) MEN1POLBKMT2AALDH1A1GAA
SCHEMBL17645107 0.77 MEN1 (0.58) MEN1POLBKMT2AALDH1A1GAA
SCHEMBL14962430 0.76 SLC6A3 (0.41) GSRCA12CA1CA2CA9
SCHEMBL17645324 0.75 CNR1 (0.70) CNR1CNR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0689435-A1 USE OF SUBSTITUTED ALKYL NITRATES FOR THE TREATMENT OF PATHOLOGICALLY INCREASED INTRA-OCULAR PRESSURE BYK NEDERLAND BV (NL) 1996-01-03 EP claimed
WO-1994021248-A1 USE OF SUBSTITUTED ALKYL NITRATES FOR THE TREATMENT OF PATHOLOGICALLY INCREASED INTRA-OCULAR PRESSURE BYK NEDERLAND BV (NL) 1994-09-29 WO claimed
US-5049694-A Cardiovascular disorders CEDONA PHARMACEUTICALS B.V. (NL) 1991-09-17 US disclosed
EP-0359335-A2 Pharmaceutical composition having relaxing activity which contains a nitrate ester as active substance CEDONA PHARMACEUTICALS B.V. (NL) 1990-03-21 EP disclosed